Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Ventricular Fibrillation

fluorodeoxyglucose f18 has been researched along with Ventricular Fibrillation in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Berger, RD; Calkins, H; Chrispin, J; Derakhshan, A; Gilotra, NA; Gowani, Z; Habibi, M; Misra, S; Okada, DR; Smith, J; Tandri, H; Zimmerman, SL1
Cai, MS; Chen, L; Gu, M; Hu, YR; Hua, W; Jing, R; Niu, HX; Sun, XX; Yang, SW; Zhang, NX; Zhang, S1
Ahmed, J; Feiglin, D; Liu, K1
Inoko, M; Nakane, E; Nakasone, K; Sekihara, T1
Krause, BJ; Mau, J; Müller, HW; Poeppel, TD; Reinhardt, M; Strauer, BE; Vester, EG; Vosberg, H; Yong, M1

Other Studies

5 other study(ies) available for fluorodeoxyglucose f18 and Ventricular Fibrillation

ArticleYear
Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
    The American journal of cardiology, 2020, 11-01, Volume: 134

    Topics: Adult; Aged; Cardiomyopathies; Death, Sudden, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Sarcoidosis; Tachycardia, Ventricular; Ventricular Fibrillation

2020
Global and regional cardiac dysfunction quantified by
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:2

    Topics: Adult; Aged; Cardiac Imaging Techniques; Defibrillators, Implantable; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Tachycardia, Ventricular; Tomography, Emission-Computed, Single-Photon; Ventricular Fibrillation; Ventricular Function, Left

2021
A 54-year-old man with new-onset ventricular fibrillation.
    Heart (British Cardiac Society), 2017, Volume: 103, Issue:23

    Topics: Biopsy; Cardiomyopathies; Cardiopulmonary Resuscitation; Defibrillators; Electric Countershock; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome; Ventricular Fibrillation

2017
Ventricular fibrillation via torsade des pointes of cardiac sarcoidosis with preserved left ventricular ejection fraction.
    BMJ case reports, 2016, Oct-25, Volume: 2016

    Topics: Aged; Biopsy; Cardiomyopathies; Contrast Media; Defibrillators, Implantable; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Stroke Volume; Torsades de Pointes; Ventricular Fibrillation

2016
Myocardial perfusion/metabolism mismatch and ventricular arrhythmias in the chronic post infarction state.
    Nuklearmedizin. Nuclear medicine, 2005, Volume: 44, Issue:3

    Topics: Coronary Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Fibrillation

2005